Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Vera Therapeutics A | VERA | 22. nov 2024 | 48.31 | +2.72 |
Veracyte | VCYT | 22. nov 2024 | 39.59 | +1.67 |
Veralto | VLTO | 22. nov 2024 | 106.41 | +0.38 |
Verastem | VSTM | 22. nov 2024 | 4.00 | +1.78 |
Verb Technology | VERB | 22. nov 2024 | 8.94 | +8.50 |
Verde Clean Fuels | VGAS | 22. nov 2024 | 4.17 | -2.11 |
Veren | VRN | 22. nov 2024 | 5.43 | +0.56 |
Vericel | VCEL | 22. nov 2024 | 59.11 | +4.23 |
VerifyMe | VRME | 22. nov 2024 | 0.62 | -11.86 |
Verint Systems | VRNT | 22. nov 2024 | 24.43 | +2.47 |
Veris Residential | VRE | 22. nov 2024 | 18.43 | +0.22 |
VeriSign | VRSN | 22. nov 2024 | 180.77 | -2.23 |
Verisk Analytics | VRSK | 22. nov 2024 | 290.73 | +1.10 |
Veritex | VBTX | 22. nov 2024 | 30.07 | +2.38 |
Veritone | VERI | 22. nov 2024 | 2.73 | -0.18 |
Verizon Communications | VZ | 22. nov 2024 | 43.15 | +1.53 |
Vermilion Energy | VET | 22. nov 2024 | 10.69 | -1.38 |
Verona Pharma ADR | VRNA | 22. nov 2024 | 38.81 | +2.51 |
Verra Mobility A | VRRM | 22. nov 2024 | 23.64 | +1.94 |
Verrica Pharmaceuticals | VRCA | 22. nov 2024 | 0.99 | +0.45 |
VersaBank | VBNK | 22. nov 2024 | 17.12 | +0.53 |
Versus Systems | VS | 22. nov 2024 | 1.65 | +3.77 |
Vertex A | VERX | 22. nov 2024 | 53.83 | +0.73 |
Vertex Energy | VTNR | 22. nov 2024 | 0.11 | 0.00 |
Vertex Pharmaceuticals | VRTX | 22. nov 2024 | 450.97 | +0.13 |
Vertical Aerospace | EVTL | 22. nov 2024 | 4.79 | -0.21 |
Vertiv Holdings A | VRT | 22. nov 2024 | 140.15 | -0.95 |
Veru | VERU | 22. nov 2024 | 0.68 | +7.50 |
Verve Therapeutics | VERV | 22. nov 2024 | 4.85 | +5.43 |
Vestis | VSTS | 22. nov 2024 | 16.02 | +2.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.